Figure A (Lovenox 01)
Lovenox Injection
Product Images NDC 0075-0626
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 32 technical images submitted to the FDA as part of the official labeling for Lovenox (NDC 0075-0626). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sanofi-aventis U.s. Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure B (Lovenox 02)
Figure C (Lovenox 03)
Figure D (Lovenox 04)
Figure E (Lovenox 05)
Chemical Structure (Lovenox 06)
Chemical Structure (Lovenox 07)
Figure 1 (Lovenox 08)
This appears to be a table with various subgroups of patients in a study, along with the number of patents in each subgroup and their characteristics such as age, gender, diabetes status, fibrinolytic agent used, and time of treatment. The last row may represent the total number of patients in the study.*
Figure 2 (Lovenox 09)
Principal Display Panel (30 mg/0.3 mL Syringe Carton)
Principal Display Panel (40 mg/0.4 mL Syringe Carton)
Principal Display Panel (60 mg/0.6 mL Syringe Carton)
Principal Display Panel (80 mg/0.8 mL Syringe Carton)
Principal Display Panel (100 mg/1 mL Syringe Carton)
Principal Display Panel (300 mg/3 mL Vial Carton)
Principal Display Panel (120 mg/0.8 mL Syringe Carton)
Principal Display Panel (150 mg/1 mL Syringe Carton)
Lovenox 18
Lovenox 19
Lovenox 20
Lovenox 21
Lovenox 22
Lovenox 23
Lovenox 24
Lovenox 25
Lovenox® is a medication in the form of enoxaparin sodium injection that is derived from porcine intestinal mucosa. It is recommended to be used for subcutaneous injection with a dosage mentioned in the package insert. The medication is designed to be stored at 25°C (77°F) with permitted excursions to 15-30°C (59-86°F). It is a single-dose syringe equipped with an automatic safety device. There are no specific instructions provided for administration but they may be found in the package insert. The text also includes some additional information about the product's manufacturer, Sanofiaventis US, LLC.*
Lovenox 26
Lovenox® is a medication that contains 40mg of enoxaparin sodium derived from porcine intestinal mucosa in each syringe. It is intended for subcutaneous injection and the dosage information and directions are provided in the package insert. The syringes are equipped with an automatic safety device for subcutaneous injection. It is important to keep Lovenox® out of reach of children and to store it at 25°C (77°F). The text includes directions for using Lovenox® Single Dose syringes with automatic safety devices and a data matrix code.*
Lovenox 27
LOVENOX® is a medication available in single-dose syringes with automatic safety devices for subcutaneous injection. Each syringe includes 60mg of enoxaparin sodium injection extracted from porcine intestinal mucosa in water for injection. The dosage must be adjusted depending on the patient's condition, age, weight, and any other medication they are taking. Store the medication at room temperature, but avoid high excursions above 30°C or below 15°C. You must confirm the correct dose before injecting the medication subcutaneously. The instructions for use and dosage information are described in the package insert. Keep LOVENOX® out of reach of children.*
Lovenox 28
Lovenox® is a medication available in the form of single-dose syringes with an automatic safety device for subcutaneous injection. Each syringe contains 80mg of enoxaparin sodium injection derived from porcine intestinal mucosa in water for injection. The dosage and administration should be done by following the instructions provided in the package insert. It is important to keep the syringes out of reach of children and store them at controlled room temperature. The syringe's safety device can only be activated once the syringe is removed from the patient. The medicine is produced by Sanofi-aventis, and the area on the package is reserved for serialization.*
Lovenox 29
Lovenax® is a medication that is administered subcutaneously through injection. The main ingredient is enoxaparin sodium, which is derived from porcine intestinal mucosa. Each syringe of Lovenax contains 100mg of the substance. The package insert contains the information and dosage guidelines for use. The syringe features an automatic safety device. A single graduation on the syringe equals 25mg of enoxaparin sodium. The solution can be stored at a temperature of 25°C and with excursions permitted up to 15-30°C. The medication must be kept out of reach of children. The prescription drug is intended for a single-use only. The text also includes a warning and company information.*
Lovenox 30
LOVENOX® is an injectable medication containing 10mg of enoxaparin sodium derived from porcine intestinal mucosa and 1.5mg of benzyl alcohol. It is used for subcutaneous or intravenous injection, and dosage information can be found in the package insert. LOVENOX® should be kept out of reach of children and stored between 15-30°C (59-86°F). Multiple dose vials should not be stored for more than 28 days after the first use.*
Lovenox 31
Lovenox is a drug that contains 120mg of enoxaparin sodium injection derived from porcine intestinal mucosa in Water for Injection. It is administered for subcutaneous injection using a single-dose syringe with an automatic safety device. Each 0.02mL graduation equals 3mg of enoxaparin sodium injection. There are ten 0.8mL syringes in a packet, and dosage information and directions for use can be found in the package insert. Keep Lovenox out of reach of children and store at a temperature between 15-30°C (59-86°F). The activation of the safety system may cause minimal splatter, and the syringe should be immediately disposed of in a sharps container.*
Lovenox 32
Lovenox is a medication that contains 150mg of enoxaparin sodium injection derived from porcine intestinal mucosa. It is used for subcutaneous injection and comes in single-dose syringes with an automatic safety device. The dosage information and directions can be found in the package insert. Lovenox should be stored at 25°C and kept out of reach of children. The text includes a warning to dispose of the syringe in a sharps container after use. The rest of the text is illegible or contains non-English characters.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
